Seoul, South Korea

Byeong-Chun Lee

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: H Bion Co., Ltd., Other. Active years: 2003-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byeong-Chun Lee. Retrieved from https://idiyas.com/inventor/byeong-chun-lee-zgd0xlu7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 


Average Co-Inventor Count = 13.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Byeong-Chun Lee: Innovator in Stem Cell Research

Introduction

Byeong-Chun Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, holding a total of 3 patents. His work focuses on the development of embryonic stem cell lines through innovative techniques.

Latest Patents

Lee's latest patents include groundbreaking advancements in neuro-progenitor cells. One of his notable inventions is a neuro-progenitor produced from a somatic cell nuclear transfer (SCNT)-derived embryonic stem cell. This embryonic stem cell line is created by transferring the nucleus of a human somatic cell into an enucleated human oocyte, allowing it to differentiate into various desired cell types. Another patent involves a similar process, emphasizing the potential of human embryonic stem cell lines prepared through nuclear transfer.

Career Highlights

Throughout his career, Byeong-Chun Lee has worked with various organizations, including H Bion Co., Ltd. His expertise in stem cell technology has positioned him as a key figure in the research community.

Collaborations

Lee has collaborated with notable scientists in his field, including Woo-Suk Hwang and Sung-Il Roh. These partnerships have furthered his research and contributed to advancements in stem cell applications.

Conclusion

Byeong-Chun Lee's innovative work in stem cell research has led to significant advancements in the field. His patents reflect a commitment to exploring the potential of embryonic stem cells, paving the way for future developments in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…